HealthTechMovers.com has identified several healthtech stocks which are expected to go “Ex-Dividend” very soon. Remember, if you purchase a stock on its ex-dividend date or after, you will not receive the next dividend payment. Instead, the seller gets the dividend. If you purchase before the ex-dividend date, you get the dividend.
FinMarketNews.com is looking into these tickers DAWN, MTDR, AVY, CMC, MNST, RTX and more.
If you sell your stock before the ex-dividend date, you also are selling away your right to the stock dividend.
So please keep this in mind.
Below is our latest Dividend Report:
Abbott Labs
Symbol: ABT
Recent ABT Price: $113.85
Average Analyst Price Target: $119.85 (5.27%)
ABT Market Cap: $195.86B
Expected Ex-Dividend Date for ABT stock: Jan 12 2023
Expected Payment Date for ABT stock: Feb 15 2023
Expected Dividend & Yield for ABT stock: 1.67%
Recent Analyst Action: Cecilia Furlong, analyst at Morgan Stanley, reiterates coverage on Abbott Labs (ABT) stock in the Healthcare sector with a Buy rating and a price target of $ 133 (4 days ago).
Click for full story on ABT stock >>Recent Analyst Action: Robyn Karnauskas, analyst at Truist Financial, reiterates coverage on AbbVie (ABBV) stock in the Healthcare sector with a Buy rating and a price target of $ 180 (5 days ago).
Click for full story on ABBV stock >>